Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
209.00 HKD | +3.36% |
|
-1.42% | +51.01% |
07-10 | China's market regulator holds symposium on fair competition | RE |
07-09 | China's market regulator holds symposium on fair competition | RE |
Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 7.15 | 6.94 | 7.52 | 9.66 | 9.68 | |||||
Return on Total Capital | 8.89 | 8.72 | 9.49 | 12.11 | 12.17 | |||||
Return On Equity % | 14.78 | 17.57 | 18.45 | 24.78 | 22.36 | |||||
Return on Common Equity | 16.8 | 19 | 19.71 | 25.69 | 22.59 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 52.92 | 53.62 | 54.68 | 60.95 | 62.5 | |||||
SG&A Margin | 19.11 | 18.81 | 18.76 | 18.24 | 17.76 | |||||
EBITDA Margin % | 24.43 | 22.48 | 23.3 | 29.73 | 30.39 | |||||
EBITA Margin % | 19.85 | 18.84 | 20.44 | 26.88 | 28.2 | |||||
EBIT Margin % | 19.74 | 18.74 | 20.34 | 26.78 | 28.1 | |||||
Income From Continuing Operations Margin % | 16.74 | 19.38 | 19.92 | 28.37 | 28.73 | |||||
Net Income Margin % | 16.37 | 19.24 | 21.08 | 28.43 | 28.2 | |||||
Net Avail. For Common Margin % | 16.37 | 19.24 | 20.43 | 28.43 | 28.2 | |||||
Normalized Net Income Margin | 12.68 | 14.92 | 16.22 | 20.63 | 20.67 | |||||
Levered Free Cash Flow Margin | 21.99 | 18.33 | 19.23 | 18 | 24.5 | |||||
Unlevered Free Cash Flow Margin | 22.2 | 18.46 | 19.65 | 18.53 | 24.85 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.58 | 0.59 | 0.59 | 0.58 | 0.55 | |||||
Fixed Assets Turnover | 14.15 | 14.85 | 14.08 | 12.89 | 11.77 | |||||
Receivables Turnover (Average Receivables) | 16.85 | 17.37 | 18.36 | 18.11 | 17.42 | |||||
Inventory Turnover (Average Inventory) | 54.54 | 52.22 | 44.66 | 47.84 | 62.34 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 2.31 | 2.24 | 2.32 | 2.65 | 3.09 | |||||
Quick Ratio | 2.14 | 2.07 | 2.18 | 2.53 | 2.94 | |||||
Operating Cash Flow to Current Liabilities | 0.53 | 0.49 | 0.49 | 0.66 | 0.8 | |||||
Days Sales Outstanding (Average Receivables) | 21.73 | 21.01 | 19.88 | 20.15 | 21.01 | |||||
Days Outstanding Inventory (Average Inventory) | 6.71 | 6.99 | 8.17 | 7.63 | 5.87 | |||||
Average Days Payable Outstanding | 12.39 | 9.43 | 10.39 | 10.87 | 7.45 | |||||
Cash Conversion Cycle (Average Days) | 16.04 | 18.56 | 17.66 | 16.91 | 19.44 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 21.65 | 21.82 | 26.14 | 15.99 | 8.99 | |||||
Total Debt / Total Capital | 17.8 | 17.91 | 20.72 | 13.79 | 8.25 | |||||
LT Debt/Equity | 0.51 | 2.02 | 3.97 | 0.77 | 0.59 | |||||
Long-Term Debt / Total Capital | 0.42 | 1.66 | 3.15 | 0.66 | 0.54 | |||||
Total Liabilities / Total Assets | 33.89 | 35.29 | 36.98 | 31.11 | 27.3 | |||||
EBIT / Interest Expense | 58.67 | 85.82 | 30.19 | 31.34 | 49.47 | |||||
EBITDA / Interest Expense | 74.37 | 105.98 | 35.4 | 35.19 | 53.93 | |||||
(EBITDA - Capex) / Interest Expense | 70.11 | 97.6 | 32.17 | 32.58 | 51.8 | |||||
Total Debt / EBITDA | 1.1 | 1.07 | 1.24 | 0.66 | 0.4 | |||||
Net Debt / EBITDA | -3.97 | -3.75 | -3.87 | -3.42 | -3.87 | |||||
Total Debt / (EBITDA - Capex) | 1.17 | 1.16 | 1.36 | 0.71 | 0.41 | |||||
Net Debt / (EBITDA - Capex) | -4.21 | -4.07 | -4.26 | -3.69 | -4.03 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 24.35 | 18.92 | 10.15 | 7.23 | 1.77 | |||||
Gross Profit, 1 Yr. Growth % | 23.54 | 20.49 | 12.34 | 19.51 | 4.35 | |||||
EBITDA, 1 Yr. Growth % | 9.7 | 9.43 | 14.19 | 36.81 | 4.02 | |||||
EBITA, 1 Yr. Growth % | 5.48 | 12.87 | 19.49 | 41.03 | 6.78 | |||||
EBIT, 1 Yr. Growth % | 5.42 | 12.92 | 19.56 | 41.17 | 6.77 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -8.45 | 37.68 | 13.21 | 52.76 | 3.06 | |||||
Net Income, 1 Yr. Growth % | -43.2 | 39.74 | 20.65 | 44.64 | 0.96 | |||||
Normalized Net Income, 1 Yr. Growth % | -7.03 | 39.94 | 19.74 | 36.38 | 1.97 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -11.76 | 39.17 | 19.36 | 51.34 | 1.55 | |||||
Accounts Receivable, 1 Yr. Growth % | 9.76 | 20.36 | -9.17 | 28.37 | -11.73 | |||||
Inventory, 1 Yr. Growth % | -4.51 | 63.1 | 3 | -30.02 | -17.81 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 4.78 | 21.7 | 11.61 | 22.05 | 2.68 | |||||
Total Assets, 1 Yr. Growth % | 26.53 | 8.3 | 12.44 | 7.62 | 5.41 | |||||
Tangible Book Value, 1 Yr. Growth % | 35.85 | 19.73 | 9.45 | 20.91 | 12.68 | |||||
Common Equity, 1 Yr. Growth % | 33.64 | 16.07 | 9.86 | 18.67 | 11.59 | |||||
Cash From Operations, 1 Yr. Growth % | 44.56 | 0.15 | 11.16 | 27.51 | 12.3 | |||||
Capital Expenditures, 1 Yr. Growth % | -12.72 | 51.75 | 31.12 | 9.58 | -44.59 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 0.66 | -0.87 | 15.56 | 0.37 | 38.52 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 1.62 | -1.08 | 17.22 | 1.13 | 36.48 | |||||
Dividend Per Share, 1 Yr. Growth % | -46.65 | 45.21 | 28.71 | 90.11 | 3.75 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 19.98 | 21.61 | 14.45 | 8.68 | 4.46 | |||||
Gross Profit, 2 Yr. CAGR % | 19.4 | 22 | 16.34 | 15.87 | 11.68 | |||||
EBITDA, 2 Yr. CAGR % | 22.27 | 9.57 | 11.78 | 24.99 | 19.3 | |||||
EBITA, 2 Yr. CAGR % | 20.87 | 9.11 | 16.13 | 29.81 | 22.71 | |||||
EBIT, 2 Yr. CAGR % | 20.71 | 9.11 | 16.19 | 29.92 | 22.77 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 19.63 | 12.27 | 24.85 | 31.5 | 25.47 | |||||
Net Income, 2 Yr. CAGR % | 40.02 | -10.91 | 29.85 | 32.1 | 20.84 | |||||
Normalized Net Income, 2 Yr. CAGR % | 18.85 | 14.07 | 29.45 | 27.79 | 17.93 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 18.82 | 10.81 | 28.88 | 34.4 | 23.97 | |||||
Accounts Receivable, 2 Yr. CAGR % | 6.93 | 14.94 | 4.56 | 7.98 | 6.45 | |||||
Inventory, 2 Yr. CAGR % | -23.65 | 21.78 | 29.61 | -15.1 | -24.16 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 6.79 | 12.86 | 16.55 | 16.71 | 11.95 | |||||
Total Assets, 2 Yr. CAGR % | 27.72 | 17.06 | 10.35 | 10 | 6.51 | |||||
Tangible Book Value, 2 Yr. CAGR % | 36.42 | 27.54 | 14.48 | 15.04 | 16.73 | |||||
Common Equity, 2 Yr. CAGR % | 34.75 | 24.55 | 12.93 | 14.18 | 15.07 | |||||
Cash From Operations, 2 Yr. CAGR % | 36.2 | 20.33 | 5.52 | 19.05 | 19.66 | |||||
Capital Expenditures, 2 Yr. CAGR % | -30.25 | 15.08 | 41.06 | 19.87 | -22.07 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 43.21 | -0.11 | 6.52 | 7.3 | 16.64 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 43.89 | 0.26 | 7.68 | 8.88 | 17.49 | |||||
Dividend Per Share, 2 Yr. CAGR % | 44.99 | -11.99 | 36.71 | 56.43 | 40.45 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 18.35 | 19.62 | 17.66 | 11.99 | 6.32 | |||||
Gross Profit, 3 Yr. CAGR % | 15.89 | 19.76 | 18.69 | 17.39 | 11.9 | |||||
EBITDA, 3 Yr. CAGR % | 9.29 | 17.83 | 11.08 | 19.57 | 17.57 | |||||
EBITA, 3 Yr. CAGR % | 3.99 | 18.14 | 12.47 | 23.9 | 21.63 | |||||
EBIT, 3 Yr. CAGR % | 3.81 | 18.06 | 12.49 | 23.98 | 21.69 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 1.81 | 25.37 | 12.58 | 33.53 | 21.24 | |||||
Net Income, 3 Yr. CAGR % | 4.05 | 39.93 | -1.43 | 34.6 | 20.78 | |||||
Normalized Net Income, 3 Yr. CAGR % | 3.16 | 25.5 | 15.93 | 31.72 | 18.53 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 1.14 | 25.25 | 13.59 | 35.97 | 22.41 | |||||
Accounts Receivable, 3 Yr. CAGR % | 8.13 | 11.23 | 6.26 | 11.96 | 0.97 | |||||
Inventory, 3 Yr. CAGR % | -51.59 | -3.26 | 15.16 | 5.54 | -16.01 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 12.23 | 11.51 | 12.45 | 18.35 | 11.84 | |||||
Total Assets, 3 Yr. CAGR % | 25.94 | 20.89 | 15.5 | 9.43 | 8.45 | |||||
Tangible Book Value, 3 Yr. CAGR % | 18.37 | 30.61 | 21.2 | 16.58 | 14.25 | |||||
Common Equity, 3 Yr. CAGR % | 21.55 | 28.21 | 19.45 | 14.81 | 13.31 | |||||
Cash From Operations, 3 Yr. CAGR % | 27.92 | 22.94 | 17.19 | 12.39 | 16.76 | |||||
Capital Expenditures, 3 Yr. CAGR % | -13.91 | -9.62 | 20.2 | 29.67 | -7.31 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 54.9 | 26.68 | 4.86 | 4.43 | 16.84 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 55.4 | 26.99 | 5.62 | 5.46 | 17.4 | |||||
Dividend Per Share, 3 Yr. CAGR % | 9.33 | 45.07 | -0.1 | 52.6 | 36.42 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 26.43 | 18.07 | 16.78 | 15.12 | 12.19 | |||||
Gross Profit, 5 Yr. CAGR % | 23.8 | 16.74 | 16.07 | 18.19 | 15.84 | |||||
EBITDA, 5 Yr. CAGR % | 19.28 | 8.73 | 10.28 | 20.64 | 14.3 | |||||
EBITA, 5 Yr. CAGR % | 14.99 | 5.48 | 8.68 | 22.68 | 16.46 | |||||
EBIT, 5 Yr. CAGR % | 14.86 | 5.39 | 8.6 | 22.67 | 16.49 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 12.52 | 7.56 | 10.47 | 27.79 | 17.57 | |||||
Net Income, 5 Yr. CAGR % | 12.36 | 7.75 | 13.69 | 36.74 | 6.94 | |||||
Normalized Net Income, 5 Yr. CAGR % | 13.46 | 9 | 12.96 | 26.41 | 16.72 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 12.03 | 7.38 | 11.44 | 28.83 | 17.63 | |||||
Accounts Receivable, 5 Yr. CAGR % | 11.85 | 5.32 | 6.69 | 9.92 | 6.34 | |||||
Inventory, 5 Yr. CAGR % | -5.35 | -9.37 | -28.92 | -8.18 | -2.56 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 20.56 | 21.77 | 13.91 | 13.56 | 12.25 | |||||
Total Assets, 5 Yr. CAGR % | 28.08 | 21.5 | 19.45 | 16.41 | 11.82 | |||||
Tangible Book Value, 5 Yr. CAGR % | 20.6 | 18.7 | 16.8 | 24.14 | 19.39 | |||||
Common Equity, 5 Yr. CAGR % | 22.94 | 20.07 | 18.02 | 22.4 | 17.68 | |||||
Cash From Operations, 5 Yr. CAGR % | 25.24 | 9.98 | 18.44 | 21.37 | 18.17 | |||||
Capital Expenditures, 5 Yr. CAGR % | 4.03 | 7.12 | 4.89 | 1.19 | 1.07 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 23.98 | 10.18 | 33.61 | 18.72 | 9.9 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 24.21 | 10.34 | 34.19 | 19.41 | 10.22 | |||||
Dividend Per Share, 5 Yr. CAGR % | 14.19 | 10.16 | 19.55 | 49.51 | 14.48 |
- Stock Market
- Equities
- 9999 Stock
- Financials NetEase, Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition